Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Pulseless ventricular tachycardia primary prevention
Introduction
Overview
Overview
Implantable cardiac defibrillators are recommended in high-risk patients i.e, patients with dilated cardiomyopathy for the primary prevention of pulseless ventricular tachycardia.
Primary Prevention
Primary Prevention
- Implantable cardiac defibrillators are recommended in high-risk patients 1.e, patients with dilated cardiomyopathy for the primary prevention of pulseless ventricular tachycardia.[1]
- Implantable cardiac defibrillators have shown to significantly decrease mortality rates when compared to medical treatment for the prevention of sudden cardiac death.[2]
References
References
- ↑ Callaway CW (January 2013). “Epinephrine for cardiac arrest”. Curr. Opin. Cardiol. 28 (1): 36–42. doi:10.1097/HCO.0b013e32835b0979. PMID 23196774.
- ↑ Kusumoto FM, Bailey KR, Chaouki AS, Deshmukh AJ, Gautam S, Kim RJ, Kramer DB, Lambrakos LK, Nasser NH, Sorajja D (October 2018). “Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society”. Heart Rhythm. 15 (10): e253–e274. doi:10.1016/j.hrthm.2017.10.037. PMID 29097318.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]